Skip to main content

Reproductive Endocrinology Reference Intervals for Transgender Women on Stable Hormone Therapy.

Publication ,  Journal Article
Greene, DN; Schmidt, RL; Winston McPherson, G; Rongitsch, J; Imborek, KL; Dickerson, JA; Drees, JC; Humble, RM; Nisly, N; Dole, NJ; Dane, SK ...
Published in: J Appl Lab Med
January 12, 2021

BACKGROUND: Transgender women and nonbinary people seeking feminizing therapy are often prescribed estrogen as a gender-affirming hormone, which will alter their reproductive hormone axis. Testosterone, estradiol, and other reproductive hormones are commonly evaluated to assess therapy, but reference intervals specific to transgender women have not been established. The objective of this study was to derive reference intervals for commonly measured analytes related to reproductive endocrinology in a cohort of healthy gender nonconforming individuals on stable feminizing hormone therapy. METHODS: Healthy transgender individuals who had been prescribed estrogen (n = 93) for at least a year were recruited from internal medicine and primary care clinics that specialize in transgender medical care. Total testosterone and estradiol were measured using immunoassay and mass spectrometry; LH, FSH, sex hormone binding globulin, prolactin, progesterone, anti-mullerian hormone (AMH), and dehydroepiandrosterone sulfate (DHEAS) were measured using immunoassay; free testosterone was calculated. Reference intervals (central 95%) were calculated according to Clinical Laboratory Standards Institute guidelines. RESULTS: The distribution of results for transgender women was different than what would be expected from cisgender men or women across all measurements. Use of spironolactone was associated with changes in the result distribution of AMH, FSH, LH, and progesterone. Compared to liquid chromatography coupled to tandem mass spectrometry (LC/MS/MS), immunoassay was sufficient for the majority of estradiol and total testosterone measurements; free testosterone added little clinical value beyond total testosterone. CONCLUSION: Reference intervals specific to transgender women should be applied when evaluating reproductive endocrine analytes. Spironolactone is a significant variable for result interpretation of some tests.

Duke Scholars

Published In

J Appl Lab Med

DOI

ISSN

2576-9456

Publication Date

January 12, 2021

Volume

6

Issue

1

Start / End Page

15 / 26

Location

England

Related Subject Headings

  • Transgender Persons
  • Testosterone
  • Tandem Mass Spectrometry
  • Reference Values
  • Male
  • Humans
  • Female
  • 3205 Medical biochemistry and metabolomics
  • 3202 Clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Greene, D. N., Schmidt, R. L., Winston McPherson, G., Rongitsch, J., Imborek, K. L., Dickerson, J. A., … Krasowski, M. D. (2021). Reproductive Endocrinology Reference Intervals for Transgender Women on Stable Hormone Therapy. J Appl Lab Med, 6(1), 15–26. https://doi.org/10.1093/jalm/jfaa028
Greene, Dina N., Robert L. Schmidt, Gabrielle Winston McPherson, Jessica Rongitsch, Katherine L. Imborek, Jane A. Dickerson, Julia C. Drees, et al. “Reproductive Endocrinology Reference Intervals for Transgender Women on Stable Hormone Therapy.J Appl Lab Med 6, no. 1 (January 12, 2021): 15–26. https://doi.org/10.1093/jalm/jfaa028.
Greene DN, Schmidt RL, Winston McPherson G, Rongitsch J, Imborek KL, Dickerson JA, et al. Reproductive Endocrinology Reference Intervals for Transgender Women on Stable Hormone Therapy. J Appl Lab Med. 2021 Jan 12;6(1):15–26.
Greene, Dina N., et al. “Reproductive Endocrinology Reference Intervals for Transgender Women on Stable Hormone Therapy.J Appl Lab Med, vol. 6, no. 1, Jan. 2021, pp. 15–26. Pubmed, doi:10.1093/jalm/jfaa028.
Greene DN, Schmidt RL, Winston McPherson G, Rongitsch J, Imborek KL, Dickerson JA, Drees JC, Humble RM, Nisly N, Dole NJ, Dane SK, Frerichs J, Krasowski MD. Reproductive Endocrinology Reference Intervals for Transgender Women on Stable Hormone Therapy. J Appl Lab Med. 2021 Jan 12;6(1):15–26.

Published In

J Appl Lab Med

DOI

ISSN

2576-9456

Publication Date

January 12, 2021

Volume

6

Issue

1

Start / End Page

15 / 26

Location

England

Related Subject Headings

  • Transgender Persons
  • Testosterone
  • Tandem Mass Spectrometry
  • Reference Values
  • Male
  • Humans
  • Female
  • 3205 Medical biochemistry and metabolomics
  • 3202 Clinical sciences